FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015830049> ?p ?o ?g. }

• W3015830049 endingPage "2000013" @default.
• W3015830049 startingPage "2000013" @default.
• W3015830049 abstract "Ex vivo culture of viable circulating tumor cells (CTCs) from individual patients has recently become an emerging liquid biopsy technology to investigate drug sensitivity and genomic analysis in cancer. However, it remains challenging to retrieve the CTCs with high viability and purity from cancer patients' blood using a rapid process. Here, a triple selection strategy that combines immunonegative enrichment, density gradient, and microfluidic-based size-exclusion methods is developed for in situ drug sensitivity testing. The CTC isolation chip consists of 4 independent microchannels that can evenly distribute the captured CTCs, allowing for independent in situ analysis event. The cancer cells are retrieved within 5 min with high viability (>95%), captured efficiency (78%), and high purity (99%) from 7.5 mL of blood cell mixed samples. Furthermore, the CTCs can be isolated from prostate cancer patients' blood samples and verified in situ using cancer-specific markers within 1.5 h, demonstrating the possibility to be applied to clinical practice. In situ drug sensitivity analysis demonstrates that the captured CTCs without and with cisplatin treatment for 1 day have survival rates of 87.5% and 0%, respectively. It is envisioned that this strategy may become a potential tool to identify suitable therapies prior to the treatment." @default.
• W3015830049 created "2020-04-17" @default.
• W3015830049 creator A5012220374 @default.
• W3015830049 creator A5037349631 @default.
• W3015830049 creator A5053003426 @default.
• W3015830049 creator A5055502013 @default.
• W3015830049 creator A5078325063 @default.
• W3015830049 creator A5084877325 @default.
• W3015830049 creator A5086754083 @default.
• W3015830049 date "2020-04-08" @default.
• W3015830049 modified "2023-09-26" @default.
• W3015830049 title "Triple Selection Strategy for In Situ Labeling of Circulating Tumor Cells with High Purity and Viability toward Preclinical Personalized Drug Sensitivity Analysis" @default.
• W3015830049 cites W1846262441 @default.
• W3015830049 cites W1911720892 @default.
• W3015830049 cites W1917588793 @default.
• W3015830049 cites W1959010197 @default.
• W3015830049 cites W1974785337 @default.
• W3015830049 cites W1995097523 @default.
• W3015830049 cites W2012987872 @default.
• W3015830049 cites W2027735722 @default.
• W3015830049 cites W2039468203 @default.
• W3015830049 cites W2079032404 @default.
• W3015830049 cites W2093758129 @default.
• W3015830049 cites W2102864709 @default.
• W3015830049 cites W2104883825 @default.
• W3015830049 cites W2110598242 @default.
• W3015830049 cites W2117994949 @default.
• W3015830049 cites W2119764457 @default.
• W3015830049 cites W2142114070 @default.
• W3015830049 cites W2161661776 @default.
• W3015830049 cites W2163473969 @default.
• W3015830049 cites W2265816584 @default.
• W3015830049 cites W2287313802 @default.
• W3015830049 cites W2294395959 @default.
• W3015830049 cites W2339825717 @default.
• W3015830049 cites W2481456694 @default.
• W3015830049 cites W2588287202 @default.
• W3015830049 cites W2590954301 @default.
• W3015830049 cites W2601380465 @default.
• W3015830049 cites W2604783384 @default.
• W3015830049 cites W2606876496 @default.
• W3015830049 cites W2740569386 @default.
• W3015830049 cites W2790914328 @default.
• W3015830049 cites W2794015436 @default.
• W3015830049 cites W2800938577 @default.
• W3015830049 cites W2903204479 @default.
• W3015830049 cites W2911273283 @default.
• W3015830049 cites W2916157147 @default.
• W3015830049 cites W2942421163 @default.
• W3015830049 cites W2944209562 @default.
• W3015830049 cites W2948005896 @default.
• W3015830049 cites W2949005354 @default.
• W3015830049 cites W2963858429 @default.
• W3015830049 cites W2964495724 @default.
• W3015830049 cites W2996853256 @default.
• W3015830049 doi "https://doi.org/10.1002/adbi.202000013" @default.
• W3015830049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32529799" @default.
• W3015830049 hasPublicationYear "2020" @default.
• W3015830049 type Work @default.
• W3015830049 sameAs 3015830049 @default.
• W3015830049 citedByCount "5" @default.
• W3015830049 countsByYear W30158300492020 @default.
• W3015830049 countsByYear W30158300492021 @default.
• W3015830049 countsByYear W30158300492022 @default.
• W3015830049 crossrefType "journal-article" @default.
• W3015830049 hasAuthorship W3015830049A5012220374 @default.
• W3015830049 hasAuthorship W3015830049A5037349631 @default.
• W3015830049 hasAuthorship W3015830049A5053003426 @default.
• W3015830049 hasAuthorship W3015830049A5055502013 @default.
• W3015830049 hasAuthorship W3015830049A5078325063 @default.
• W3015830049 hasAuthorship W3015830049A5084877325 @default.
• W3015830049 hasAuthorship W3015830049A5086754083 @default.
• W3015830049 hasConcept C119857082 @default.
• W3015830049 hasConcept C121608353 @default.
• W3015830049 hasConcept C126322002 @default.
• W3015830049 hasConcept C127413603 @default.
• W3015830049 hasConcept C178790620 @default.
• W3015830049 hasConcept C185592680 @default.
• W3015830049 hasConcept C21200559 @default.
• W3015830049 hasConcept C24326235 @default.
• W3015830049 hasConcept C2777822432 @default.
• W3015830049 hasConcept C2779013556 @default.
• W3015830049 hasConcept C2780035454 @default.
• W3015830049 hasConcept C41008148 @default.
• W3015830049 hasConcept C502942594 @default.
• W3015830049 hasConcept C61238886 @default.
• W3015830049 hasConcept C70721500 @default.
• W3015830049 hasConcept C71924100 @default.
• W3015830049 hasConcept C81917197 @default.
• W3015830049 hasConcept C86803240 @default.
• W3015830049 hasConcept C98274493 @default.
• W3015830049 hasConceptScore W3015830049C119857082 @default.
• W3015830049 hasConceptScore W3015830049C121608353 @default.
• W3015830049 hasConceptScore W3015830049C126322002 @default.
• W3015830049 hasConceptScore W3015830049C127413603 @default.
• W3015830049 hasConceptScore W3015830049C178790620 @default.
• W3015830049 hasConceptScore W3015830049C185592680 @default.
• W3015830049 hasConceptScore W3015830049C21200559 @default.

• next